BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2248 related articles for article (PubMed ID: 8234201)

  • 1. Preparation of purified tyrosinase devoid of dopachrome tautomerase from mammalian malignant melanocytes.
    Valverde P; Jiménez-Cervantes C; Salinas C; García-Borrón JC; Solano F; Lozano JA
    Pigment Cell Res; 1993 Jun; 6(3):158-64. PubMed ID: 8234201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of dopachrome tautomerase in human melanocytes cultured in vitro.
    Bernd A; Ramirez-Bosca A; Kippenberger S; Martinez-Liarte JH; Holzmann H; Solano F
    Melanoma Res; 1994 Oct; 4(5):287-91. PubMed ID: 7858411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the final phase of mammalian melanogenesis. The role of dopachrome tautomerase and the ratio between 5,6-dihydroxyindole-2-carboxylic acid and 5,6-dihydroxyindole.
    Aroca P; Solano F; Salinas C; García-Borrón JC; Lozano JA
    Eur J Biochem; 1992 Aug; 208(1):155-63. PubMed ID: 1511683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase.
    Tsukamoto K; Jackson IJ; Urabe K; Montague PM; Hearing VJ
    EMBO J; 1992 Feb; 11(2):519-26. PubMed ID: 1537333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of tyrosinase, tyrosinase-related proteins 1 and 2 (TRP1 and TRP2), the silver protein, and a melanogenic inhibitor in human melanoma cells of differing melanogenic activities.
    Kameyama K; Sakai C; Kuge S; Nishiyama S; Tomita Y; Ito S; Wakamatsu K; Hearing VJ
    Pigment Cell Res; 1995 Apr; 8(2):97-104. PubMed ID: 7659683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells.
    Rad HH; Yamashita T; Jin HY; Hirosaki K; Wakamatsu K; Ito S; Jimbow K
    Exp Cell Res; 2004 Aug; 298(2):317-28. PubMed ID: 15265682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-MSH and other melanogenic activators mediate opposite effects on tyrosinase and dopachrome tautomerase in B16/F10 mouse melanoma cells.
    Martínez-Liarte JH; Solano F; García-Borrón JC; Jara JR; Lozano JA
    J Invest Dermatol; 1992 Oct; 99(4):435-9. PubMed ID: 1328399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopachrome tautomerase is a zinc-containing enzyme.
    Solano F; Martinez-Liarte JH; Jiménez-Cervantes C; García-Borrón JC; Lozano JA
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1243-50. PubMed ID: 7980602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of TRPs from murine and human malignant melanocytes.
    Martinez-Esparza M; Jiménez-Cervantes C; García-Borrón JC; Lozano JA; del Marmol V; Ghanem G; Solano F
    Pigment Cell Res; 1997 Aug; 10(4):229-35. PubMed ID: 9263330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of melanin monomers, dihydroxyindole-2-carboxylic acid (DHICA) and dihydroxyindole (DHI) on mammalian tyrosinase, with a special reference to the role of DHICA/DHI ratio in melanogenesis.
    Wilczek A; Mishima Y
    Pigment Cell Res; 1995 Apr; 8(2):105-12. PubMed ID: 7659677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of melanogenesis inhibition by tumor necrosis factor-alpha in B16/F10 mouse melanoma cells.
    Martínez-Esparza M; Jiménez-Cervantes C; Solano F; Lozano JA; García-Borrón JC
    Eur J Biochem; 1998 Jul; 255(1):139-46. PubMed ID: 9692912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DHICA oxidase activity of the melanosomal tyrosinases LEMT and HEMT.
    Jiménez-Cervantes C; Solano F; Lozano JA; García-Borrón JC
    Pigment Cell Res; 1994 Oct; 7(5):298-304. PubMed ID: 7886002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of melanogenesis induced by 5-methoxypsoralen without ultraviolet light in murine melanoma cells.
    Mengeaud V; Ortonne JP
    Pigment Cell Res; 1994 Aug; 7(4):245-54. PubMed ID: 7855073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosinase isoenzymes in mammalian melanocytes. 2. Differential activation by alpha-melanocyte-stimulating hormone.
    Valverde P; Garcia-Borron JC; Jimenez-Cervantes C; Solano F; Lozano JA
    Eur J Biochem; 1993 Oct; 217(2):541-8. PubMed ID: 7901010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and biological control of melanogenesis through tyrosinase genes and intrinsic and extrinsic regulatory factors.
    Mishima Y
    Pigment Cell Res; 1994 Dec; 7(6):376-87. PubMed ID: 7761345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PUVA (5-methoxypsoralen plus UVA) enhances melanogenesis and modulates expression of melanogenic proteins in cultured melanocytes.
    Mengeaud V; Ortonne JP
    J Invest Dermatol; 1996 Jul; 107(1):57-62. PubMed ID: 8752840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pigment production in murine melanoma cells is regulated by tyrosinase, tyrosinase-related protein 1 (TRP1), DOPAchrome tautomerase (TRP2), and a melanogenic inhibitor.
    Kameyama K; Takemura T; Hamada Y; Sakai C; Kondoh S; Nishiyama S; Urabe K; Hearing VJ
    J Invest Dermatol; 1993 Feb; 100(2):126-31. PubMed ID: 8429235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopachrome tautomerase decreases the binding of indolic melanogenesis intermediates to proteins.
    Salinas C; García-Borrón JC; Solano F; Lozano JA
    Biochim Biophys Acta; 1994 Jan; 1204(1):53-60. PubMed ID: 8305475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced glutathione disrupts the intracellular trafficking of tyrosinase and tyrosinase-related protein-1 but not dopachrome tautomerase and Pmel17 to melanosomes, which results in the attenuation of melanization.
    Nakajima H; Nagata T; Koga S; Imokawa G
    Arch Dermatol Res; 2014 Jan; 306(1):37-49. PubMed ID: 23764898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amphotericin B on dopachrome tautomerase activity and other melanogenic parameters in cultured B16/F10 melanoma cells.
    Peinado P; Martínez-Liarte JH; Solano F; Lozano JA
    Pigment Cell Res; 1992 Dec; 5(6):400-3. PubMed ID: 1492075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 113.